[1]
M. A. Mohammed AL-Naqqash, “Chromogranin A: As A Tumor Marker for Neuroendocrine Tumors Diagnosis, Follow-up & Its Correlation with Response to Somatostatin Analogues”, JFacMedBagdad, vol. 58, no. 4, pp. 307–311, Jan. 2016, doi: 10.32007/jfacmedbagdad.584270.